Angiology
The use of statins is associated with a reduced risk of venous thromboembolism
Published in Women's Health Weekly, November 25th, 2004
According to a study from France, "Previous studies of selected patients have suggested a reduction in the risk of venous thromboembolism with the use of statins. The objective of this study is to evaluate the influence of statin use on the risk of venous thromboembolic (VTE) events. The study is a case-control study (EDITH: Etude des Determinants et Interactions de la Thrombose Veincuse), designed to investigate the genetic and environmental risk factors of VTE."
K. Lacut and colleagues of the Hopital de la Cavale...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Bacterial Vaginosis
Bacteria more likely to develop resistance to clindamycin than metronidazole - Breast Cancer
Fruits, vegetables may decrease some women's risk of ER-positive cancer - Cervical Cancer
Study: No justification for colposcopy in screening of young women - Heart Surgery
Women at greater risk of leg infection after heart surgery than men - Systemic Lupus Erythematosus
Newly identified biomarkers could lead to quicker, better diagnosis of lupus - Abortion
Abortion clinic says it will not require parental consent - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
